In ' major milestone, ' FDA approves first cell therapy for solid tumors
Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from…#iovance #allisonbetofwarner #stanforduniversity #betofwarner
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Immunotherapy | Melanoma | Skin Cancer